Comparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by Focusing on Fatty Acid Metabolism

PURPOSE: Sodium-glucose co-transporter-2 (SGLT2) inhibitors have various pleiotropic effects, including body weight reduction, and therefore have the potential to be used in various applications. However, such effects have not been fully investigated; thus, non-clinical studies using animal models a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawarasaki, Satoko, Sawazaki, Honami, Iijima, Hiroaki, Ng, Su-Ping, Kwon, Jungin, Mohri, Shinsuke, Iwase, Mari, Jheng, Huei-Fen, Takahashi, Haruya, Nomura, Wataru, Inoue, Kazuo, Kawada, Teruo, Goto, Tsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678695/
https://www.ncbi.nlm.nih.gov/pubmed/33235475
http://dx.doi.org/10.2147/DMSO.S269916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678695/
https://www.ncbi.nlm.nih.gov/pubmed/33235475
http://dx.doi.org/10.2147/DMSO.S269916

Ejemplares similares